IPO PerformanceHTFL continues to perform well, up 60%+ since the August 8th IPO, and investor enthusiasm for the stock is easy to understand.
Market Growth PotentialHeartflow is minimally penetrated in the $3.1B coronary blood flow market and remains in the early launch stages of the $2.9B plaque analysis market, favorably positioned for continued share gains.
Technology AdvancementsManagement highlighted that image processing times have been reduced from as long as 18-19 hours in 2014 to under 30 minutes today, supporting the gross margin expansion seen in recent years.